These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6737250

  • 1. Disintegrating force as a new formulation parameter.
    Colombo P, Conte U, Caramella C, Geddo M, La Manna A.
    J Pharm Sci; 1984 May; 73(5):701-5. PubMed ID: 6737250
    [Abstract] [Full Text] [Related]

  • 2. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
    Massimo G, Catellani PL, Santi P, Bettini R, Vaona G, Bonfanti A, Maggi L, Colombo P.
    Pharm Dev Technol; 2000 May; 5(2):163-9. PubMed ID: 10810746
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
    Que L, Wu W, Cheng X, Hu T.
    Pharm Dev Technol; 2006 May; 11(3):295-301. PubMed ID: 16895840
    [Abstract] [Full Text] [Related]

  • 4. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K, Kanada K, Uchida S, Yamada M, Namiki N.
    Chem Pharm Bull (Tokyo); 2011 May; 59(8):959-64. PubMed ID: 21804239
    [Abstract] [Full Text] [Related]

  • 5. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS, Vural I, Sahin S, Ertugrul A, Capan Y.
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [Abstract] [Full Text] [Related]

  • 6. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
    Massimo G, Santi P, Colombo G, Nicoli S, Zani F, Colombo P, Bettini R.
    AAPS PharmSciTech; 2003 Feb; 4(2):E17. PubMed ID: 12916899
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
    Yıldız S, Aytekin E, Yavuz B, Bozdağ Pehlivan S, Vural İ, Ünlü N.
    Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
    [Abstract] [Full Text] [Related]

  • 8. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S, Aytekin E, Yavuz B, Bozdağ Pehlivan S, Ünlü N.
    Drug Dev Ind Pharm; 2016 Jun; 42(6):1008-17. PubMed ID: 26530146
    [Abstract] [Full Text] [Related]

  • 9. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system.
    Gülbağ S, Yılmaz Usta D, Gültekin HE, Oktay AN, Demirtaş Ö, Karaküçük A, Çelebi N.
    Pharm Dev Technol; 2018 Jun; 23(5):512-519. PubMed ID: 28657404
    [Abstract] [Full Text] [Related]

  • 10. Varying efficacy of superdisintegrants in orally disintegrating tablets among different manufacturers.
    Mittapalli RK, Qhattal HS, Lockman PR, Yamsani MR.
    Pharmazie; 2010 Nov; 65(11):805-10. PubMed ID: 21155386
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
    Morita Y, Tsushima Y, Yasui M, Termoz R, Ajioka J, Takayama K.
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
    [Abstract] [Full Text] [Related]

  • 12. Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.
    Lin SY, Li MJ, Lin KH.
    AAPS PharmSciTech; 2004 Aug 16; 5(4):e54. PubMed ID: 15760051
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W, Jachowicz R, Krupa A, Skorka T, Niwinski K.
    Pharm Dev Technol; 2013 Aug 16; 18(2):464-74. PubMed ID: 22881600
    [Abstract] [Full Text] [Related]

  • 14. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 15. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P, Kandasamy R.
    AAPS PharmSciTech; 2017 Aug 15; 18(6):1972-1986. PubMed ID: 27921260
    [Abstract] [Full Text] [Related]

  • 16. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA.
    Acta Pharm; 2005 Sep 15; 55(3):263-76. PubMed ID: 16375837
    [Abstract] [Full Text] [Related]

  • 17. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E, Antal B, Zsadon B, Szejtli J.
    Pharmazie; 1984 Jul 15; 39(7):473-5. PubMed ID: 6494226
    [Abstract] [Full Text] [Related]

  • 18. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA, Augsburger LL.
    Drug Dev Ind Pharm; 2012 Jul 15; 38(7):825-36. PubMed ID: 22091970
    [Abstract] [Full Text] [Related]

  • 19. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
    Morott JT, Pimparade M, Park JB, Worley CP, Majumdar S, Lian Z, Pinto E, Bi Y, Durig T, Repka MA.
    J Pharm Sci; 2015 Jan 15; 104(1):124-34. PubMed ID: 25410968
    [Abstract] [Full Text] [Related]

  • 20. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D, Bhandari A, Gaur PK, Yasir M, Kumar SS, Choudhary D, Saxena PK.
    Curr Clin Pharmacol; 2018 Jan 15; 13(2):128-135. PubMed ID: 29521214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.